ELTX

Elicio Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-12

Figures on this page computed 2026-11-08 13:15 UTC

Last close

1.56USD

Market data, 2026-11-04

ELTX: weekly closes from 10.63 on 2026-05-15 to 1.56 on 2026-11-04, a move of -85.3%. Prices in USD.

Weekly closes, 2026-05-15 to 2026-11-04

Over that span: -85.3%

Except where said otherwise: 10-K for 2025, filed 2026-03-12

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-12
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
8.87Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.32 against 0.71 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

n/a

1.13x

1.57x

1.51x

0.23x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-12

Salesn/a
Its own average over 7 years, 7.6M.
Profit1.13x
Its own average over 10 years, -34.9M.
Free cash flow1.57x
Its own average over 10 years, -23.6M.
Debt1.51x
Its own average over 9 years, 9.6M.
Price0.23x
Its own average over 4 years, 7. Market data, 2026-11-04

Price is furthest from its own average, at 0.23 times.

The filed years, as a table

Each line is 100 at 2012-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2012-12-31	100.0	100.0	n/a
2013-12-31	90.2	205.7	n/a
2018-12-31	55.2	-6,516.4	n/a
2019-12-31	20.4	-13,230.6	n/a
2020-12-31	39.5	-26,067.8	100.0
2021-12-31	388.0	-17,758.7	191.3
2022-12-31	31.5	-9,179.2	21.4
2023-12-31	n/a	-11,452.9	342.5
2024-12-31	n/a	-16,888.2	826.6
2025-12-31	n/a	-12,876.9	1,037.3

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001601485-26-000027
Reported in: USD

The filing itself

How profit was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001601485-26-000027
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001601485-26-000027
Reported in: USD

The filing itself

Figures behind the shape

Growth

23.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income23.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-2418.8%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on equity-2418.8%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on assets-153.0%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself

Margins

n/a

We do not hold this figure for this company, so there is nothing to place.

wider is higher, with no cohort held

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself

Price

14.1x

cheaper is higher, placed against 4,482 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-12
The filing itself
Price to book14.1x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001601485-26-000056
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-13
- computed
- 10-K for 2025, filed 2026-03-12
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-12
The filing itself
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself

Safety

8.87

safer is higher, placed against 4,231 companies as of 2026-11-07

Debt to equity8.87
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-Q for 2025, filed 2026-08-13
The filing itself
Current ratio2.3810-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001601485-26-000056
Reported in
USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-12
- Computed from the 10-K for 2025, filed 2026-03-12
- Computed from the 10-K for 2025, filed 2026-03-12
- Computed from the 10-K for 2025, filed 2026-03-12
- Computed from the 10-K for 2025, filed 2026-03-12

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001601485-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-03-12
- Computed from the 10-K for 2025, filed 2026-03-12
- 10-K for 2025, filed 2026-03-12
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.